1. Home
  2. EVO vs USPH Comparison

EVO vs USPH Comparison

Compare EVO & USPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.65

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo U.S. Physical Therapy Inc.

USPH

U.S. Physical Therapy Inc.

HOLD

Current Price

$81.68

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
USPH
Founded
1993
1990
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2021
1992

Fundamental Metrics

Financial Performance
Metric
EVO
USPH
Price
$3.65
$81.68
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$7.00
$106.50
AVG Volume (30 Days)
251.6K
190.5K
Earning Date
11-05-2025
02-25-2026
Dividend Yield
N/A
2.27%
EPS Growth
N/A
153.49
EPS
N/A
2.38
Revenue
$887,396,457.00
$750,948,000.00
Revenue This Year
N/A
$19.53
Revenue Next Year
$8.52
$6.33
P/E Ratio
N/A
$33.44
Revenue Growth
N/A
17.51
52 Week Low
$2.84
$62.77
52 Week High
$4.80
$93.50

Technical Indicators

Market Signals
Indicator
EVO
USPH
Relative Strength Index (RSI) 71.06 55.39
Support Level $3.10 $78.61
Resistance Level $3.23 $85.40
Average True Range (ATR) 0.08 3.31
MACD 0.08 0.11
Stochastic Oscillator 96.87 56.55

Price Performance

Historical Comparison
EVO
USPH

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About USPH U.S. Physical Therapy Inc.

US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.

Share on Social Networks: